Literature DB >> 10510169

The cellular and developmental expression of hrs-2 in rat.

S Tsujimoto1, M Pelto-Huikko, M Aitola, B Meister, E O Vik-Mo, S Davanger, R H Scheller, A J Bean.   

Abstract

The molecular events underlying vesicular trafficking probably involve the formation and dissolution of protein complexes between integral components of the vesicle and its target membrane. SNAP-25 is associated with the plasma membrane and is a component of a core protein complex thought to be essential for neurotransmitter release. We have previously characterized a protein, hrs-2, that interacts with SNAP-25 and inhibits secretion from permeabilized PC12 cells. The cellular localization and developmental expression patterns of a number of proteins involved in the secretion machinery have been documented. To understand more about the possible cellular role of hrs-2, we have examined hrs-2 distribution, developmental expression and subcellular localization in rat tissues and cell lines. We show herein that the distribution of hrs-2 in brain and periphery parallels that of SNAP-23/25, and that recombinant hrs-2 binds to both SNAP-23 and SNAP-25. Hrs-2 mRNA and protein are found almost ubiquitously in neurons in the brain. Hrs-2 mRNA is expressed in the neural tube at E10 and thereafter mRNA and protein levels remain relatively constant in the whole brain through adulthood. In cultured PC12 cells, endogenous hrs-2 is expressed in the cytoplasm and on the limiting membranes of multivesicular bodies. Overexpression of hrs-2 in mammalian cells results in the appearance of large intracellular compartments that are labelled with hrs-2 antibodies. The wide distribution, the interaction with SNAP-23 and the localization on multivesicular body membranes suggest a general role for hrs-2 in cellular machinery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510169     DOI: 10.1046/j.1460-9568.1999.00716.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.

Authors:  Mark Bajohrs; Colin Rickman; Thomas Binz; Bazbek Davletov
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

2.  Cell-free reconstitution of multivesicular body formation and receptor sorting.

Authors:  Wei Sun; Thomas A Vida; Natalie Sirisaengtaksin; Samuel A Merrill; Phyllis I Hanson; Andrew J Bean
Journal:  Traffic       Date:  2010-02-27       Impact factor: 6.215

3.  CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling.

Authors:  Qing Yan; Wei Sun; Pekka Kujala; Yasmin Lotfi; Thomas A Vida; Andrew J Bean
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

4.  Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1.

Authors:  M Yamada; T Takeshita; S Miura; K Murata; Y Kimura; N Ishii; M Nose; H Sakagami; H Kondo; F Tashiro; J I Miyazaki; H Sasaki; K Sugamura
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation.

Authors:  Natalie Sirisaengtaksin; Monica Gireud; Qing Yan; Yoshihisa Kubota; Denisse Meza; Jack C Waymire; Peter E Zage; Andrew J Bean
Journal:  J Biol Chem       Date:  2013-12-16       Impact factor: 5.157

6.  Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex.

Authors:  Wei Sun; Qing Yan; Thomas A Vida; Andrew J Bean
Journal:  J Cell Biol       Date:  2003-07-07       Impact factor: 10.539

7.  Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes.

Authors:  Kristi G Bache; Andreas Brech; Anja Mehlum; Harald Stenmark
Journal:  J Cell Biol       Date:  2003-08-04       Impact factor: 10.539

8.  Mycobacterium tuberculosis Type VII Secretion System Effectors Differentially Impact the ESCRT Endomembrane Damage Response.

Authors:  Ekansh Mittal; Michael L Skowyra; Grace Uwase; Emir Tinaztepe; Alka Mehra; Stefan Köster; Phyllis I Hanson; Jennifer A Philips
Journal:  MBio       Date:  2018-11-27       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.